Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection | Zendy

Jong Man Kim | Zendy; JaeWon Joh | Zendy; NamJoon Yi | Zendy; GyuSeong Choi | Zendy; Choon Hyuck David Kwon | Zendy; KwangWoong Lee | Zendy; KyungSuk Suh | Zendy

Open Access

Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection

Author(s) -

Jong Man Kim,

JaeWon Joh,

NamJoon Yi,

GyuSeong Choi,

Choon Hyuck David Kwon,

KwangWoong Lee,

KyungSuk Suh

Publication year - 2020

Publication title -

annals of translational medicine

Language(s) - English

Resource type - Journals

eISSN - 2305-5847

pISSN - 2305-5839

DOI - 10.21037/atm.2020.02.170

Subject(s) - medicine , hepatocellular carcinoma , radiofrequency ablation , milan criteria , percutaneous ethanol injection , liver transplantation , hepatectomy , gastroenterology , surgery , transplantation , ablation , resection

Long-term outcomes for patients with recurrent HCC within the MC do not differ with the first treatment strategies, except for PEI. Salvage LDLT does not prevent HCC recurrence, but it increases patient survival compared with the other treatment strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research